RE: Covid Valuation14 Oct 2020 12:02
20p for Sareum would be very cheap if things pan out as we expect. You know my views on pharma valuations such as NCYT, SNG, ODX, AVCT, HEMO, YGEN, PYC, N4P etc. i.e. the rule book gets thrown out of the window at a time like this. Good luck all Sareum shareholders, Brighty